Frederick Wilson, MD, PhD

Dr. Wilson graduated from Duke University and received his PhD at Yale University and MD at Harvard Medical School. He completed an internship and residency at Brigham and Women's Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute and Massachusetts General Hospital. He completed a research fellowship at Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT. His research focuses on the identification and characterization of genetic vulnerabilities in cancer as well as genetic determinants of sensitivity and resistance to targeted therapies.